KZR-616 Uses, Dosage, Side Effects and more

KZR-616 is under investigation in clinical trial NCT04033926 (A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis).

Trade Name KZR-616
Generic KZR-616
Type
Formula C30H42N4O8
Weight Average: 586.686
Monoisotopic: 586.300264328
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share